Close Menu

NEW YORK – With the COVID-19 pandemic expected to worsen in the US in the coming weeks, and testing capacity still playing catch-up, Emergency Use Authorizations from the US Food and Drug Administration have reached an inflection point.

Late last week the first two tests from the private sector were granted EUA, and early this week the FDA loosened its guidelines to make it easier for commercially developed tests to receive EUA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.